VentriPoint Diagnostics Ltd V.VPT

Alternate Symbol(s): VPTDF

Technology Scientific & Technical Instruments

Ventripoint Diagnostics Ltd. is a Canada-based medical device company. It is engaged in the development and commercialization of diagnostic tools to monitor patients with heart disease. It develops a suite of applications for all heart diseases and imaging modalities, including congenital heart disease, pregnancy, pulmonary hypertension, COVID-19, technically difficult imaging and cardiotoxicity in oncology patients. It provides application of artificial intelligence to echocardiography. Its flagship product, Ventripoint Medical System (VMS+), enhances echocardiography to deliver cMRI levels of accuracy for volumetric measurements and ejection fractions for all four chambers of the heart. It has developed a solution that transforms cardiac care through its 3D ECHO and MRI software. VMS products are powered by its proprietary Knowledge Based Reconstruction technology, which is the result of a decade of development and provides accurate volumetric cardiac measurements equivalent to MRI.

TSXV:VPT - Post by User

VentriPoint Diagnostics Ltd > China Joint Venture

<< Previous

Bullboard Posts

Next >>

Comment by InvrsContrarianon Feb 21, 2021 6:05pm

260 Views

Post# 32622868

RE:RE:RE:RE:RE:China Joint Venture

The version 2 is not being sold. The version 3 is the product now. GA didn't mention anything about agreements with China and the factory. Dunno if it's relevant with version 3 being far superior to version 2.time.for some. Email$ To the big guy. Any takers?

G1945V wrote: So is this a form of a license agreement to manufacture units in China for an X percentage of gross sales?

This agreement must be posted somewhere.

G1945V